‘Rod cells are responsible for dim-light vision, cone cells for daylight and colour, and ‘rod-cone dystrophy’ is simply the name given to whichever group breaks down first. In this particular pattern it is the rods that go first, with cone involvement joining only later — and that sequence is exactly what places most classic cases of retinitis pigmentosa within this category. It carries clinical significance because it reliably predicts which visual abilities fade earliest and which continue functioning the longest.
For a patient from Tanzania who arrives with this precise term already written on a referral note, understanding that rod-first sequence removes a lot of the guesswork right from the first conversation.

Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience

Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience

Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
Care follows the same regenerative and supportive framework used across the progressive dystrophies — stem cell therapy is evaluated for patients whose test results suggest they are reasonable candidates, paired with practical guidance for adjusting to reduced night and peripheral vision while central vision remains comparatively stable for longer.
“There is considerable overlap between the two. ‘Rod-cone dystrophy’ describes the order the disease follows — rods first, cones later — and that particular order applies to most cases that end up clinically labelled retinitis pigmentosa.”
”
It comes down to which cell type fails first. Rod-cone dystrophy affects night and peripheral vision early while central and colour vision hold up longer; cone-rod dystrophy runs the reverse course, with central and colour vision affected sooner.”
“In many rod-cone cases, eventually yes — central vision can decline once the disease has progressed far enough to reach the cones, though the timeline for that shift varies considerably by gene and by individual patient.”
“That is decided on a case-by-case basis, guided by how quickly ERG and field results shift after the initial evaluation. Some patients only need annual review, while others with a faster-moving pattern are seen more frequently.”
